Shawn Cross is Chief Financial Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 56,250 shares of PCRX, which is worth approximately $1.34 Million. The most recent transaction as insider was on Dec 10, 2025, when has been sold 9,104 shares (Common Stock) at a price of $25.14 per share, resulting in proceeds of $228,874. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.3K
25.0% 3M change
25.0% 12M change
Total Value Held $1.34 Million

Shawn Cross Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 10 2025
SELL
Open market or private sale
$228,874 $25.14 p/Share
9,104 Reduced 13.93%
56,250 Common Stock
Dec 10 2025
BUY
Exercise of conversion of derivative security
$149,760 $16.45 p/Share
9,104 Added 12.23%
65,354 Common Stock
Dec 09 2025
SELL
Open market or private sale
$397,876 $25.03 p/Share
15,896 Reduced 22.03%
56,250 Common Stock
Dec 09 2025
BUY
Exercise of conversion of derivative security
$261,489 $16.45 p/Share
15,896 Added 18.06%
72,146 Common Stock
Nov 10 2025
SELL
Open market or private sale
$266,405 $22.09 p/Share
12,060 Reduced 17.65%
56,250 Common Stock
Oct 31 2025
SELL
Payment of exercise price or tax liability
$143,032 $21.38 p/Share
6,690 Reduced 8.92%
68,310 Common Stock
Nov 01 2024
BUY
Grant, award, or other acquisition
-
75,000 Added 50.0%
75,000 Common Stock

Also insider at

AMTI
Applied Molecular Transport Inc. Healthcare
CYTH
Cyclo Therapeutics, Inc. Healthcare
SC

Shawn Cross

Chief Financial Officer
South San Francisco, CA

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Track Activities on PCRX